Penn Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History
Bought
Maintained
Sold
Other funds holding CELL
AIM
GCM
NIMC
Penn Capital Management's CELL Position: Q3 2022 in Review
Penn Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2022, closing a stake of 87,224 shares — an estimated $434K sold.
Penn Capital Management first reported a position in CELL in Q2 2022 and held it in 1 quarter. The position peaked at $434K in Q2 2022. 113 funds tracked by Wall St. Rank hold CELL as of Q3 2022.
- Penn Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Penn Capital Management sold 87,224 PhenomeX Inc. Common Stock shares in Q3 2022, an estimated $434K.
- Penn Capital Management first reported a position in PhenomeX Inc. Common Stock in Q2 2022 and held it in 1 quarter.
- Penn Capital Management's PhenomeX Inc. Common Stock position peaked at $434K in Q2 2022.
- 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2022.
Based on Penn Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.